CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation

被引:42
|
作者
Saliba, Walid [1 ,2 ,3 ]
Rennert, Gad [1 ,2 ,4 ]
机构
[1] Technion Israel Inst Technol, Clalit Hlth Serv, Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[3] Haemek Med Ctr, IL-18101 Afula, Israel
[4] Clalit Hlth Serv Headquarters, Off Chief Phys, Dept Epidemiol & Dis Prevent, Tel Aviv, Israel
来源
AMERICAN JOURNAL OF MEDICINE | 2014年 / 127卷 / 01期
关键词
Atrial fibrillation; CHA(2)DS(2)-VASc; Mortality; Pulmonary embolism; DEEP VENOUS THROMBOSIS; VEIN THROMBOSIS; SERUM 25(OH)D; THROMBOEMBOLISM; STROKE; ATHEROSCLEROSIS; GUIDELINES; MANAGEMENT; POPULATION; MORTALITY;
D O I
10.1016/j.amjmed.2013.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The risk stratification score, which includes Congestive heart failure, Hypertension, Age >= 75 [doubled], Diabetes, Stroke [doubled]-Vascular disease, Age 65-74, and Sex category [female] (CHA(2)DS(2)-VASc), is used to predict stroke in atrial fibrillation. However, whether high CHA(2)DS(2)-VASc score carries a higher risk of pulmonary embolism remains unknown. We aimed to investigate the association between the severity of CHA(2)DS(2)-VASc score and the incidence of pulmonary embolism. METHODS: A total of 73,541 adults with atrial fibrillation diagnosed before January 1, 2012, and no history of pulmonary embolism, were retrospectively identified from the computerized database of the Clalit Health Services, which is the largest not-for-profit health maintenance organization in Israel. The CHA(2)DS(2)-VASc score was calculated for each subject at study entry. The cohort was followed for the first occurrence of pulmonary embolism until December 31, 2012 (70,210 person-years). RESULTS: Pulmonary embolism developed in 158 subjects, representing an incidence of 225.0 per 100,000 person-years. The incidence of pulmonary embolism increased with increasing CHA(2)DS(2)-VASc score (P <.001). On Cox proportional analysis, CHA(2)DS(2)-VASc score was significantly associated with pulmonary embolism (hazard ratio, 1.22; 95% confidence interval [CI], 1.13-1.32) for a 1-point increase in CHA(2)DS(2)VASc score. The results were similar after adjusting for anticoagulants and antiplatelet use (hazard ratio, 1.24; 95% CI, 1.14-1.34), and remained unchanged after further adjustment for active malignancy. The predictive values for pulmonary embolism were similar for CHA(2)DS(2)-VASc score and the classic risk stratification score which includes Congestive heart failure, Hypertension, Age > 75 years, Diabetes, and Stroke [doubled] (CHADS(2)); the areas under the receiver operating characteristic curves were 0.619 (95% CI, 0.579-0.660) and 0.616 (95% CI, 0.575-0.656), respectively. CONCLUSIONS: CHA(2)DS(2)-VASc score is directly associated with the incidence of pulmonary embolism in atrial fibrillation. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [31] Patients with atrial fibrillation and CHA2DS2-VASc score 1: "To anticoagulate or not to anticoagulate? That is the question!"
    Patti, Giuseppe
    Cavallari, Ilaria
    HEART RHYTHM, 2015, 12 (12) : 2515 - 2520
  • [32] Predictors of LAA thrombi in patients with atrial fibrillation and low CHA2DS2-VASc score
    Nedios, S.
    Seewoester, T.
    Koutalas, S.
    Kornej, J.
    Rolf, S.
    Arya, A.
    Sommer, P.
    Husser, D.
    Hindricks, G.
    Bollmann, A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1083 - 1083
  • [33] Benefit of Anticoagulation Unlikely in Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1
    Friberg, Leif
    Skeppholm, Mika
    Terent, Andreas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (03) : 225 - 232
  • [34] Antithrombotic treatment for patients with paroxysmal atrial fibrillation and a low CHA2DS2-VASc score
    Muscente, Francesca
    De Caterina, Raffaele
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2017, 18 : e94 - e99
  • [35] RETRACTED: The CHA2DS2-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL, 2015, 36 (42) : 2880 - 2885
  • [36] Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation
    Chao, T. F.
    Lip, G. Y. H.
    Chen, S. A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1006 - 1006
  • [37] Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients
    Garcia-Fernandez, Amaya
    Roldan, Vanessa
    Rivera-Caravaca, Jose Miguel
    Lip, Gregory Y. H.
    Marin, Francisco
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 38 : E21 - E22
  • [38] CHA2DS2-VASc Score Is Associated With Prognosis in Patients With Acute Ischemic Stroke Without Atrial Fibrillation
    Song, Mingjuan
    Chen, Xu
    TEXAS HEART INSTITUTE JOURNAL, 2025, 52 (01)
  • [39] CHA2DS2-VASc: An eligible score for atrial fibrillation prediction in chronic obstructive pulmonary disease?
    Goudis, Christos A.
    Vasileiadis, Ioannis E.
    Liu, Tong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 257 : 299 - 299
  • [40] Efficacy of subclinical atrial fibrillation screening by AliveCor in patients with CHA2DS2-VASc score ≥ 2
    Leung, S. C.
    Yung, C. Y.
    Chan, K.
    Lee, K. L.
    Lau, Y. K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 202 - 202